Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

During the Trading Day
580.94 +26.67 / +4.81%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
582.00 +1.06 / +0.18%
 
Volume: 14.3K

Today’s Trading

Previous close554.27
Today’s open586.00
Day’s range578.21 - 605.93
Volume1,930,563
Average volume (3 months)727,565
Market cap$57.2B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+11.77%
Earnings growth (next 5 years)+25.29%
Revenue growth (last year)+33.96%
P/E ratio186.1
Price/Sales16.50
Price/Book22.33

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.34-0.27%
QQuintiles Transnatio...+0.38+0.49%
ISISIsis Pharmaceuticals...+1.34+2.48%
ICLRICON PLC-0.26-0.32%
Data as of 4:03pm ET, 08/04/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)$2.78
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts